An infusion of stem cells could help restore proper drainage for fluid-clogged eyes at risk for glaucoma. That's the upshot of a study led by a Veterans Affairs and University of Iowa team.
CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...
CAR T-cell therapy involves collecting a patient’s immune cells and engineering them to recognize and destroy cancer cells before returning them to the body through an IV infusion. This process takes ...
Hosted on MSN
Diabetes milestone: In major breakthrough, stem cell infusion restores insulin production in type 1 patients
In a first-of-its-kind clinical trial, scientists from the University of Toronto have shown that a single infusion of zimislecel — an allogeneic stem cell-derived islet therapy — can restore natural ...
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study) The aim of this open-label, ...
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback